Join to View Full Profile
800 Washington StBoston, MA 02111
Phone+1 617-636-8148
Fax+1 203-863-4738
Dr. Pai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2005
Harvard Medical SchoolClass of 2001
Certifications & Licensure
HI State Medical License 2024 - 2026
MA State Medical License 2013 - 2026
NY State Medical License 2004 - 2012
CT State Medical License 2005 - 2008
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy Start of enrollment: 2022 Jan 03
- NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer Start of enrollment: 2020 Nov 24
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors.Xiao Hu, Angie Mae Rodday, Anastasia Gurinovich, Stacey Pan, Yana V Salei
Immunotherapy. 2025-04-04 - Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non-small-cell lung cancer.Kibum Kim, Sakil Syeed, Trang Au, Amber Diaz, Matthew B Schabath
Cancer Treatment and Research Communications. 2025-03-13 - Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis.Diana Zhang, Shayesteh Jahanfar, Judy B Rabinowitz, Joshua Dower, Fei Song
Breast Cancer Research. 2025-03-12
Press Mentions
- Neuroimmunological Adverse Events Associated with Immune Checkpoint Inhibitor: A Retrospective, Pharmacovigilance Study Using FAERS DatabaseJanuary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
